STAT
JUNE 22, 2024
First Opinion is STAT’s platform for interesting, illuminating, and maybe even provocative articles about the life sciences writ large, written by biotech insiders, health care workers, researchers, and others. To encourage robust, good-faith discussion about issues raised in First Opinion essays, STAT publishes selected Letters to the Editor received in response to them.
Drug Patent Watch
JUNE 22, 2024
This chart shows the pharmaceutical companies with the most patents in Serbia. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is desired. For a global perspective, see the Drug companies with the greatest global patent coverage.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
STAT
JUNE 22, 2024
There’s a website dedicated to asking how many days it’s been since Hank Green started a new project. The counter resets often — the multi-hyphenate internet educator and science communicator rose to prominence with his 2007 YouTube project Vlogbrothers , which he founded with his brother, the novelist-turned- tuberculosis-fighter John Green.
Drug Patent Watch
JUNE 22, 2024
Dabigatran etexilate mesylate is the generic ingredient in two branded drugs marketed by Alkem Labs Ltd, Apotex, Hetero Labs Ltd Iii, and Boehringer Ingelheim and, and is included in five NDAs. There are three patents protecting this compound. Drug patent litigation for DABIGATRAN ETEXILATE MESYLATE. Nine suppliers are listed for this compound.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Pharmacy Times
JUNE 22, 2024
Semaglutide was found to have effects on glycemia, inflammation, and heart failure outcomes in sub analyses.
Drug Patent Watch
JUNE 22, 2024
MOVANTIK (naloxegol oxalate) Valinor Patent: 7,056,500 Expiration: Jun 29, 2024 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.
Pharmacist Digest brings together the best content for pharmacists from the widest variety of industry thought leaders.
Pharmacy Times
JUNE 22, 2024
Based on these results, tirzepatide could be first medication approved for treatment of obstructive sleep apnea in patients with obesity.
Pharmacy Times
JUNE 22, 2024
Managing these treatments involves many considerations, including glycemic control and nutrition, among others.
Expert insights. Personalized for you.
360 
Let's personalize your content